How would you approach adjuvant systemic therapy in a HR+ premenopausal patient over the age of 50?  

Would you recommend using chemotherapy based on RxPonder regardless of Oncotype score in a premenopausal patient? Or would you hold chemotherapy since the SI showed no clear benefit for patients over 50?

Answer from: Medical Oncologist at Community Practice

Medical Oncologist